Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04031989 · ClinicalTrials.gov registry record · NA

Repository of Phase Signals for Pulmonary Hypertension Algorithm Development

A NA study of Cardiovascular Diseases and Cardiac Disease, sponsored by Analytics For Life.

Active
Registry status
NA
Development phase
2,500
Enrollment target
17
Study locations

NCT04031989 is a NA study of Cardiovascular Diseases and Cardiac Disease that is active but no longer recruiting, run by Analytics For Life. The registered enrollment target is 2,500 participants, below the 26,966-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (91% lower). The trial reports 17 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04031989, a NA study of Cardiovascular Diseases and Cardiac Disease, is active but no longer recruiting, sponsored by Analytics For Life.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
2,500 participants
Enrollment target
17
Study locations

Study Summary

This study is designed as a repository study to collect resting cardiac phase signals and subject meta data from eligible subjects using the Phase Signal Recorder (PSR) prior to Right Heart Cath (RHC). The repository data will be used for the purposes of research, development, optimization and testing of machine-learning algorithms developed by CorVista Health (formerly Analytics 4 Life).

Conditions Studied

Cardiovascular Diseases Cardiac Disease Right Heart Failure

Interventions

  • DEVICE CorVista Capture

Study Locations (17)

North Carolina

  • Duke University - Durham
  • LeBauer Cardiovascular Research Foundation - Greensboro
  • New Hanover Regional Medical Center - Wilmington

South Carolina

  • AnMed Health - Anderson
  • Medical University of South Carolina - Charleston
  • Lexington Cardiology / Lexington Medical Heart and Vascular Center - Lexington

Colorado

  • UC-MHS (UCHealth Memorial) - Colorado Springs
  • University of Colorado-MHS (UCHealth Memorial) - Colorado Springs

Pennsylvania

  • Allegheny Health Network Research Institute - Natrona Heights
  • Allegheny Health Network Research Institute - Pittsburgh

Georgia

  • WellStar Research Institute - Marietta

Illinois

  • Loyola University Chicago - Maywood

Mississippi

  • Cardiology Associates Research, LLC - Tupelo

Nebraska

  • Bryan Heart - Lincoln

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2019-04-15
Est. Completion 2024-08-31
Phase NA

Sponsor

Analytics For Life

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04031989

The ClinicalTrials.gov registry entry for NCT04031989 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,966-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (91% lower). The listed sponsor is Analytics For Life, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which CorVista Capture is the first listed.

NCT04031989 reports 17 study locations spanning 11 distinct geographic areas - top geographies include North Carolina, South Carolina, Colorado.

Frequently Asked Questions

What is clinical trial NCT04031989 about?

NCT04031989 is a clinical study titled "Repository of Phase Signals for Pulmonary Hypertension Algorithm Development". This study is designed as a repository study to collect resting cardiac phase signals and subject meta data from eligible subjects using the Phase Signal Recorder (PSR) prior to Right Heart Cath (RHC). The repository data will be used for the purposes of research, development, optimization and testi...

What is the current status of trial NCT04031989?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 2,500 participants. The study started on 2019-04-15. Estimated completion is 2024-08-31.

What conditions does trial NCT04031989 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Cardiac Disease, Right Heart Failure.

What interventions are being tested in trial NCT04031989?

The interventions under investigation include: CorVista Capture (DEVICE).

Who is sponsoring clinical trial NCT04031989?

This trial is sponsored by Analytics For Life, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04031989 being conducted?

This trial has 17 study locations across Colorado, Georgia, Illinois, Mississippi, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cardiovascular Diseases

All registered trials for this condition

Cardiac Disease

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.